Neumora plans clinical trials, data readouts through 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Neumora plans clinical trials, data readouts through 2026
(NASDAQ: NMRA) Delayed: 3.02 +0.02 (0.67%)
Previous Close $3.00    52 Week High $ 
Open $2.96    52 Week Low $ 
Day High $3.09    P/E N/A 
Day Low $2.94    EPS $ 
Volume 1,075,983